Opinion

Video

Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3

Robert Gabbay, MD, PhD, discusses the early intervention at the asymptomatic stages of type 1 diabetes characterized by autoimmune antibodies and gradual blood sugar elevations.

Current Time 0:00
Duration 3:50
Loaded: 0%
Stream Type LIVE
Remaining Time 3:50
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Related Videos
    4 experts are featured in this series.
    Overview of Treatment Landscape for IgA Nephropathy: Standard of Care and KDIGO Guidelines
    Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
    Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
    1 expert is featured in this series.
    Ruxolitinib Cream and Atopic Dermatitis at AAD 2025
    4 experts are featured in this series.
    Clinical Impact of IgA Nephropathy and Quality of Life
    Assessing the Quality of Recommendations and Making Clinical Decisions About Lp(a) Testing
    Assessing the Quality of Recommendations and Making Clinical Decisions About Lp(a) Testing
    4 experts are featured in this series.
    Criteria for Discontinuing Treatment With an Amyloid-Targeting Therapy
    Population Outcomes and Return on Value With CGMs
    Population Outcomes and Return on Value With CGMs
    5 experts are featured in this series
    Important Updates in the Management of Uncomplicated UTIs
    5 experts are featured in this series
    Economic Burden Associated With Uncomplicated UTIs
    Health Care Quality Impact
    Health Care Quality Impact
    Related Content
    FDA headquarters | Image Credit: Tada Images - stock.adobe.com
    April 18th 2025

    5 Notable FDA Approvals From March Highlight Advancements Across Therapeutic Areas

    Brooke McCormick
    From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.
    managed care cast logo
    December 23rd 2024

    Five Years Later: Ongoing COVID-19 Challenges, Next Steps

    Brooke McCormick
    On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
    Patients who stopped adjuvant immunotherapy less than 12 months following metastatic melanoma resection did not experience inferior outcomes. | anna.stasiia - stock.adobe.com
    April 17th 2025

    Early Adjuvant Immunotherapy Discontinuation Does Not Affect Melanoma Recurrence Risk

    Jared Kaltwasser
    Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.
    Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
    December 17th 2024

    Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

    Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
    "Overactive bladder" written on sticky note | Image Credit: syahrir - stock.adobe.com
    April 15th 2025

    Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk

    Brooke McCormick
    Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer a noninvasive method to identify individuals at increased risk of developing overactive bladder.
    Patient taking survey | Image Credit: terovesalainen - stock.adobe.com
    April 15th 2025

    EHR-Based Symptom Inventory Shows Potential for Ovarian Cancer Monitoring

    Brooke McCormick
    The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ovarian cancers were diagnosed during the study period.

    2 Commerce Drive
    Suite 100
    Cranbury, NJ 08512

    © 2025 MJH Life Sciences® and AJMC®.
    All rights reserved.

    About
    Contact
    Editorial Boards
    Advertise
    Do Not Sell My Information
    Terms & Conditions
    Privacy Policy
    AJMC Managed Markets Network Logo
    CH LogoCenter for Biosimilars Logo